Cargando…
Kinetic model of metabolic network for xiamenmycin biosynthetic optimisation
Xiamenmycins, a series of prenylated benzopyran compounds with anti‐fibrotic bioactivities, were isolated from a mangrove‐derived Streptomyces xiamenensis. To fulfil the requirements of pharmaceutical investigations, a high production of xiamenmycin is needed. In this study,, the authors present a k...
Autores principales: | Xu, Min‐juan, Chen, Yong‐cong, Xu, Jun, Ao, Ping, Zhu, Xiao‐mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Institution of Engineering and Technology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687290/ https://www.ncbi.nlm.nih.gov/pubmed/26816395 http://dx.doi.org/10.1049/iet-syb.2014.0054 |
Ejemplares similares
-
Deciphering the streamlined genome of Streptomyces xiamenensis 318 as the producer of the anti-fibrotic drug candidate xiamenmycin
por: XU, Min-Juan, et al.
Publicado: (2016) -
Characterization of the Xiamenmycin Biosynthesis Gene Cluster in Streptomyces xiamenensis 318
por: Yang, Yong, et al.
Publicado: (2014) -
In Vivo Metabolism Study of Xiamenmycin A in Mouse Plasma by UPLC-QTOF-MS and LC-MS/MS
por: Lei, Feng, et al.
Publicado: (2015) -
Dynamical modelling of secondary metabolism and metabolic switches in Streptomyces xiamenensis 318
por: Zhu, Xiao-Mei, et al.
Publicado: (2019) -
Correction to: ‘Dynamical modelling of secondary metabolism and metabolic switches in Streptomyces xiamenensis 318’
por: Zhu, Xiao-Mei, et al.
Publicado: (2019)